Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 15, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2022. Go to the latest filing (Q3 2026)

20.9B USDQ2 2022
Total value of stock positions
20.9B USD
Positions
982
Share of the ten largest
10.1%

The ten largest positions Q2 2022

  1. T-Mobile US 1.8%▲ +116.8%
  2. Visa Inc. 1.3%▲ +49.6%
  3. Argenx SE 1.0%▼ −27.4%
  4. Take-Two Interactive 0.9%▲ +734.4%
  5. Fidelity National Information Services 0.9%▲ +35.2%
  6. ServiceNow 0.9%▲ +313.3%
  7. Arista Networks 0.8%▲ +14.0%
  8. Humana 0.8%▲ +45.1%
  9. Meta Platforms 0.8%▲ +145.6%
  10. ConocoPhillips 0.8%▼ −8.0%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q2 2022

Positions Q2 2022 per 13F filing, 260 of 260
Symbol Weight Shares Reported value Change Held since
Argenx SE 1.0% 574,967 217.8M USD −27.4% reduced Q1 2021 6 quarters
COP ConocoPhillips 0.8% 1,823,600 163.8M USD −8.0% reduced Q3 2020 8 quarters
SPGI S&P Global 0.8% 485,599 163.7M USD −1.1% reduced Q2 2021 5 quarters
CI Cigna 0.7% 591,239 155.8M USD −26.4% reduced Q4 2021 3 quarters
Seagen Inc 0.7% 857,822 151.8M USD −38.4% reduced Q1 2021 6 quarters
AMZN Amazon 0.7% 1,312,791 139.4M USD −25.0% reducedafter 20:1 stock split Q1 2017 22 quarters
MRK Merck & Co. 0.5% 1,196,400 109.1M USD −66.6% reduced Q2 2020 9 quarters
BKNG Booking Holdings 0.5% 61,080 106.8M USD −59.6% reduced Q1 2018 18 quarters
Krystal Biotech Inc 0.5% 1,574,275 103.4M USD −8.5% reduced Q2 2020 9 quarters
JBL Jabil 0.5% 1,980,800 101.4M USD −34.4% reduced Q2 2019 13 quarters
Select Sector SPDR TR 0.5% 1,390,000 99.4M USD −1.1% reduced Q1 2019 14 quarters
MNST Monster Beverage 0.5% 1,024,511 95.0M USD −32.1% reduced Q3 2021 4 quarters
ADI Analog Devices 0.4% 571,516 83.5M USD −60.0% reduced Q2 2020 9 quarters
BP BP (ADR) 0.4% 2,898,600 82.2M USD −23.7% reduced Q2 2021 5 quarters
LUV Southwest Airlines 0.4% 2,251,205 81.3M USD −23.1% reduced Q4 2021 3 quarters
FDX FedEx 0.4% 349,437 79.2M USD −66.4% reduced Q1 2021 6 quarters
Antero Resources Corp 0.3% 2,125,177 65.1M USD −22.8% reduced Q3 2020 8 quarters
KHC Kraft Heinz 0.3% 1,613,392 61.5M USD −3.6% reduced Q4 2021 3 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 0.3% 735,471 60.1M USD −11.8% reduced Q3 2021 4 quarters
Shell PLC 0.3% 1,097,200 57.4M USD −38.0% reduced Q1 2022 2 quarters
VMC Vulcan Materials Company 0.3% 394,179 56.0M USD −12.8% reduced Q1 2021 6 quarters
Fibrogen Inc 0.3% 5,066,292 53.5M USD −13.1% reduced Q3 2021 4 quarters
MA Mastercard 0.2% 163,726 51.7M USD −45.7% reduced Q4 2020 7 quarters
CEG Constellation Energy 0.2% 857,581 49.1M USD −37.8% reduced Q1 2022 2 quarters
Capri Holdings Limited 0.2% 1,177,370 48.3M USD −34.4% reduced Q3 2020 8 quarters
JNJ Johnson & Johnson 0.2% 267,385 47.5M USD −55.5% reduced Q3 2021 4 quarters
CSX CSX Corporation 0.2% 1,595,201 46.4M USD −19.4% reduced Q3 2020 8 quarters
Jazz Pharmaceuticals PLC 0.2% 293,269 45.8M USD −38.4% reduced Q3 2021 4 quarters
Post HLDGS Inc 0.2% 536,921 44.2M USD −54.7% reduced Q4 2020 7 quarters
GDDY GoDaddy 0.2% 614,900 42.8M USD −19.7% reduced Q3 2021 4 quarters
Lantheus HLDGS Inc 0.2% 641,311 42.3M USD −29.7% reduced Q1 2022 2 quarters
HLT Hilton Worldwide 0.2% 379,373 42.3M USD −48.9% reduced Q4 2021 3 quarters
ROST Ross Stores 0.2% 562,712 39.5M USD −44.5% reduced Q4 2021 3 quarters
Rh 0.2% 178,338 37.9M USD −35.8% reduced Q3 2021 4 quarters
DLR Digital Realty 0.2% 290,223 37.7M USD −47.3% reduced Q3 2021 4 quarters
WAT Waters Corporation 0.2% 113,466 37.6M USD −9.4% reduced Q1 2022 2 quarters
Tenable HLDGS Inc 0.2% 800,000 36.3M USD −21.0% reduced Q2 2021 5 quarters
ISRG Intuitive Surgical 0.2% 179,700 36.1M USD −22.7% reduced Q1 2021 6 quarters
Stellantis N.v 0.2% 2,855,447 35.3M USD −22.8% reduced Q1 2022 2 quarters
Texas Roadhouse Inc 0.2% 456,956 33.4M USD −43.3% reduced Q1 2020 10 quarters
Hyatt Hotels Corp 0.2% 444,410 32.8M USD −25.7% reduced Q3 2021 4 quarters
Insmed Inc 0.2% 1,660,854 32.8M USD −29.8% reduced Q3 2018 16 quarters
AVY Avery Dennison 0.2% 197,600 32.0M USD −44.1% reduced Q4 2021 3 quarters
Sarepta Therapeutics Inc 0.2% 425,507 31.9M USD −70.6% reduced Q1 2021 6 quarters
MSI Motorola Solutions 0.2% 151,835 31.8M USD −69.3% reduced Q1 2021 6 quarters
FTV Fortive 0.2% 582,400 31.7M USD −18.3% reduced Q1 2022 2 quarters
Bellring Brands Inc 0.1% 1,227,670 30.6M USD −53.9% reduced Q1 2022 2 quarters
Atara Biotherapeutics Inc 0.1% 3,877,200 30.2M USD −5.5% reduced Q4 2020 7 quarters
Xenon Pharmaceuticals Inc 0.1% 901,506 27.4M USD −58.0% reduced Q1 2015 30 quarters
Ping Identity Hldg Corp 0.1% 1,492,300 27.1M USD −12.4% reduced Q2 2021 5 quarters
Hf Sinclair Corp 0.1% 560,801 25.3M USD −31.6% reduced Q1 2022 2 quarters
Sotera Health Co 0.1% 1,241,300 24.3M USD −58.5% reduced Q4 2021 3 quarters
Bicycle Therapeutics PLC 0.1% 1,445,000 24.2M USD −10.8% reduced Q4 2019 11 quarters
Aclaris Therapeutics Inc 0.1% 1,733,900 24.2M USD −23.9% reduced Q1 2021 6 quarters
Relmada Therapeutics Inc 0.1% 1,272,574 24.2M USD −3.0% reduced Q2 2020 9 quarters
WFC Wells Fargo 0.1% 588,898 23.1M USD −25.9% reduced Q1 2021 6 quarters
KKR KKR & Co. 0.1% 497,000 23.0M USD −35.4% reduced Q3 2021 4 quarters
Qorvo Inc 0.1% 233,635 22.0M USD −60.4% reduced Q2 2021 5 quarters
Essential Utils Inc 0.1% 471,857 21.6M USD −1.9% reduced Q3 2021 4 quarters
Evolent Health Inc < 0.1% 678,702 20.8M USD −52.1% reduced Q3 2021 4 quarters
Ideaya Biosciences Inc < 0.1% 1,509,000 20.8M USD −18.3% reduced Q2 2019 13 quarters
Wendys Co < 0.1% 1,084,514 20.5M USD −56.6% reduced Q3 2021 4 quarters
Azenta Inc < 0.1% 282,380 20.4M USD −46.5% reduced Q2 2021 5 quarters
Palomar HLDGS Inc < 0.1% 307,477 19.8M USD −30.1% reduced Q4 2021 3 quarters
Privia Health Group Inc < 0.1% 660,300 19.2M USD −56.3% reduced Q4 2021 3 quarters
Berry Global Group Inc < 0.1% 350,200 19.1M USD −35.2% reduced Q2 2021 5 quarters
Stifel Finl Corp < 0.1% 334,236 18.7M USD −41.2% reduced Q3 2021 4 quarters
Forgerock Inc < 0.1% 860,034 18.4M USD −24.5% reduced Q1 2022 2 quarters
Phreesia Inc < 0.1% 731,700 18.3M USD −45.9% reduced Q1 2022 2 quarters
Angiodynamics Inc < 0.1% 927,203 17.9M USD −19.0% reduced Q4 2020 7 quarters
Affimed N V < 0.1% 6,449,020 17.9M USD −31.1% reduced Q3 2019 12 quarters
AES AES Corporation < 0.1% 850,000 17.9M USD −57.5% reduced Q3 2021 4 quarters
CBRE CBRE Group < 0.1% 240,900 17.7M USD −0.5% reduced Q1 2022 2 quarters
Carlyle Group Inc < 0.1% 559,700 17.7M USD −6.7% reduced Q3 2021 4 quarters
Rexford Indl Rlty Inc < 0.1% 304,277 17.5M USD −2.9% reduced Q1 2022 2 quarters
Arvinas Inc < 0.1% 411,548 17.3M USD −52.0% reduced Q1 2019 14 quarters
Anaptysbio Inc < 0.1% 851,800 17.3M USD −35.4% reduced Q4 2021 3 quarters
TRGP Targa Resources < 0.1% 287,342 17.1M USD −74.1% reduced Q3 2019 12 quarters
Ngm Biopharmaceuticals Inc < 0.1% 1,320,662 16.9M USD −58.9% reduced Q1 2020 10 quarters
ETR Entergy < 0.1% 150,200 16.9M USD −86.7% reduced Q1 2022 2 quarters
APD Air Products < 0.1% 69,570 16.7M USD −19.0% reduced Q1 2022 2 quarters
Pembina Pipeline Corp < 0.1% 469,800 16.6M USD −0.1% reduced Q1 2022 2 quarters
Ultragenyx Pharmaceutical In < 0.1% 273,515 16.3M USD −14.1% reduced Q4 2020 7 quarters
Pioneer Nat Res Co < 0.1% 71,137 15.9M USD −85.1% reduced Q3 2021 4 quarters
Sanofi < 0.1% 315,984 15.8M USD −76.2% reduced Q1 2018 18 quarters
Armstrong World Inds Inc New < 0.1% 210,539 15.8M USD −28.2% reduced Q1 2022 2 quarters
MRSH Marsh McLennan < 0.1% 101,400 15.7M USD −30.8% reduced Q2 2021 5 quarters
DDOG Datadog < 0.1% 157,200 15.0M USD −60.5% reduced Q2 2021 5 quarters
BF-B Brown–Forman < 0.1% 206,751 14.5M USD −33.5% reduced Q4 2021 3 quarters
Fabrinet < 0.1% 175,000 14.2M USD −58.3% reduced Q1 2021 6 quarters
Sunstone Hotel Invs Inc New < 0.1% 1,430,551 14.2M USD −14.2% reduced Q4 2021 3 quarters
DUK Duke Energy < 0.1% 131,300 14.1M USD −84.3% reduced Q4 2021 3 quarters
Arrowhead Pharmaceuticals In < 0.1% 395,868 13.9M USD −29.4% reduced Q2 2021 5 quarters
OPEN Opendoor Technologies < 0.1% 2,891,266 13.6M USD −60.1% reduced Q3 2021 4 quarters
Abiomed Inc < 0.1% 53,999 13.4M USD −39.9% reduced Q1 2022 2 quarters
Kezar Life Sciences Inc < 0.1% 1,608,400 13.3M USD −29.0% reduced Q4 2021 3 quarters
Biomarin Pharmaceutical Inc < 0.1% 147,871 12.3M USD −59.7% reduced Q3 2020 8 quarters
Shockwave Med Inc < 0.1% 62,176 11.9M USD −31.6% reduced Q4 2021 3 quarters
Macom Tech Solutions HLDGS I < 0.1% 254,200 11.7M USD −48.1% reduced Q1 2022 2 quarters
Mereo Biopharma Group PLC < 0.1% 10,035,970 11.2M USD −12.7% reduced Q1 2021 6 quarters
Archaea Energy Inc < 0.1% 723,053 11.2M USD −38.0% reduced Q4 2021 3 quarters
Lithia Mtrs Inc < 0.1% 40,800 11.2M USD −9.0% reduced Q3 2021 4 quarters
HAS Hasbro < 0.1% 134,576 11.0M USD −84.9% reduced Q4 2021 3 quarters
Irhythm Technologies Inc < 0.1% 99,427 10.7M USD −47.3% reduced Q4 2021 3 quarters
Exelixis Inc < 0.1% 512,600 10.7M USD −92.5% reduced Q1 2020 10 quarters
DOC Healthpeak Properties < 0.1% 397,383 10.3M USD −35.8% reduced Q1 2022 2 quarters
Liveperson Inc < 0.1% 698,862 9.9M USD −31.9% reduced Q3 2021 4 quarters
ASML ASML Holding (ADR) < 0.1% 19,921 9.5M USD −52.0% reduced Q3 2020 8 quarters
Academy Sports & Outdoors In < 0.1% 266,142 9.5M USD −75.0% reduced Q2 2021 5 quarters
Dyne Therapeutics Inc < 0.1% 1,366,400 9.4M USD −27.6% reduced Q1 2021 6 quarters
Azek Co Inc < 0.1% 545,000 9.1M USD −16.7% reduced Q2 2021 5 quarters
Array Technologies Inc < 0.1% 823,790 9.1M USD −35.6% reduced Q4 2020 7 quarters
WRB W. R. Berkley Corporation < 0.1% 129,461 8.8M USD −50.8% reduced Q2 2020 9 quarters
WDC Western Digital < 0.1% 189,803 8.5M USD −31.0% reduced Q3 2020 8 quarters
MTB M&T Bank < 0.1% 53,218 8.5M USD −53.2% reduced Q4 2021 3 quarters
Revance Therapeutics Inc < 0.1% 605,574 8.4M USD −23.0% reduced Q3 2021 4 quarters
Callaway Golf Co < 0.1% 401,747 8.2M USD −52.4% reduced Q1 2022 2 quarters
Oyster Pt Pharma Inc < 0.1% 1,889,096 8.2M USD −4.1% reduced Q3 2021 4 quarters
FCX Freeport-McMoRan < 0.1% 273,052 8.0M USD −39.1% reduced Q3 2021 4 quarters
Spectrum Brands HLDGS Inc Ne < 0.1% 97,010 8.0M USD −7.1% reduced Q1 2022 2 quarters
Sabra Health Care REIT Inc < 0.1% 565,924 7.9M USD −68.2% reduced Q1 2022 2 quarters
EXPD Expeditors International < 0.1% 80,100 7.8M USD −76.4% reduced Q1 2022 2 quarters
Vermilion Energy Inc < 0.1% 406,701 7.7M USD −37.6% reduced Q1 2022 2 quarters
Somalogic Inc < 0.1% 1,710,647 7.7M USD −24.9% reduced Q3 2021 4 quarters
Apollo Med HLDGS Inc < 0.1% 199,551 7.7M USD −27.8% reduced Q1 2022 2 quarters
ENPH Enphase Energy < 0.1% 39,209 7.7M USD −65.2% reduced Q3 2021 4 quarters
VICI Vici Properties < 0.1% 255,780 7.6M USD −59.6% reduced Q1 2022 2 quarters
Bunge Limited < 0.1% 83,900 7.6M USD −77.8% reduced Q2 2014 or earlier 33 quarters
Stem Inc < 0.1% 1,061,100 7.6M USD −45.1% reduced Q4 2021 3 quarters
Marketaxess HLDGS Inc < 0.1% 29,400 7.5M USD −24.7% reduced Q1 2022 2 quarters
XEL Xcel Energy < 0.1% 106,100 7.5M USD −55.0% reduced Q3 2021 4 quarters
CELH Celsius Holdings < 0.1% 113,912 7.4M USD −3.7% reduced Q1 2022 2 quarters
Rpm Intl Inc < 0.1% 90,416 7.1M USD −54.9% reduced Q1 2022 2 quarters
Dave & Busters Entmt Inc < 0.1% 213,792 7.0M USD −69.3% reduced Q3 2021 4 quarters
Kinsale Cap Group Inc < 0.1% 30,394 7.0M USD −33.0% reduced Q3 2021 4 quarters
Under Armour Inc < 0.1% 828,566 6.9M USD −63.8% reduced Q4 2020 7 quarters
Mgic Invt Corp Wis < 0.1% 527,900 6.7M USD −3.4% reduced Q3 2021 4 quarters
CFG Citizens Financial Group < 0.1% 178,353 6.4M USD −42.9% reduced Q2 2021 5 quarters
Tricida Inc < 0.1% 657,400 6.4M USD −64.2% reduced Q1 2021 6 quarters
Remitly Global Inc < 0.1% 819,785 6.3M USD −11.0% reduced Q3 2021 4 quarters
Planet Fitness Inc < 0.1% 90,126 6.1M USD −68.8% reduced Q1 2022 2 quarters
Bloomin Brands Inc < 0.1% 366,985 6.1M USD −29.5% reduced Q2 2021 5 quarters
SHIFT4 Pmts Inc < 0.1% 174,352 5.8M USD −56.4% reduced Q3 2020 8 quarters
MRVL Marvell Technology < 0.1% 122,999 5.4M USD −93.8% reduced Q1 2021 6 quarters
Adient PLC < 0.1% 179,500 5.3M USD −31.1% reduced Q1 2021 6 quarters
MET MetLife < 0.1% 82,987 5.2M USD −78.5% reduced Q1 2021 6 quarters
Continental Res Inc < 0.1% 79,458 5.2M USD −30.1% reduced Q1 2022 2 quarters
Merit Med Sys Inc < 0.1% 93,909 5.1M USD −41.4% reduced Q2 2021 5 quarters
Hertz Global HLDGS Inc < 0.1% 321,027 5.1M USD −55.2% reduced Q4 2021 3 quarters
Independence Rlty TR Inc < 0.1% 244,016 5.1M USD −55.5% reduced Q4 2021 3 quarters
Cytomx Therapeutics Inc < 0.1% 2,750,000 5.0M USD −37.1% reduced Q4 2020 7 quarters
Epr Pptys < 0.1% 105,798 5.0M USD −73.8% reduced Q1 2022 2 quarters
Pjt Partners Inc < 0.1% 69,233 4.9M USD −7.7% reduced Q1 2022 2 quarters
Vale S A < 0.1% 322,500 4.7M USD −9.8% reduced Q1 2022 2 quarters
Kb Home < 0.1% 165,100 4.7M USD −64.8% reduced Q1 2022 2 quarters
United Therapeutics Corp Del < 0.1% 19,815 4.7M USD −89.9% reduced Q2 2021 5 quarters
Pacwest Bancorp Del < 0.1% 174,848 4.7M USD −56.4% reduced Q2 2021 5 quarters
Alphatec HLDGS Inc < 0.1% 711,300 4.7M USD −13.6% reduced Q4 2020 7 quarters
Transalta Corp < 0.1% 385,000 4.4M USD −63.8% reduced Q3 2020 8 quarters
Comstock Res Inc < 0.1% 355,528 4.3M USD −60.8% reduced Q1 2022 2 quarters
EXE Expand Energy < 0.1% 52,200 4.2M USD −92.2% reduced Q1 2022 2 quarters
Olin Corp < 0.1% 90,102 4.2M USD −78.1% reduced Q1 2021 6 quarters
Toast Inc < 0.1% 306,200 4.0M USD −21.9% reduced Q1 2022 2 quarters
Golar Lng Ltd < 0.1% 172,556 3.9M USD −92.5% reduced Q2 2021 5 quarters
Hci Group Inc < 0.1% 57,307 3.9M USD −71.3% reduced Q1 2021 6 quarters
Pliant Therapeutics Inc < 0.1% 484,524 3.9M USD −37.1% reduced Q4 2021 3 quarters
Helmerich & Payne Inc < 0.1% 88,200 3.8M USD −62.2% reduced Q3 2021 4 quarters
Netstreit Corp < 0.1% 192,307 3.6M USD −35.6% reduced Q1 2022 2 quarters
Green Plains Inc < 0.1% 132,100 3.6M USD −68.9% reduced Q1 2021 6 quarters
Signet Jewelers Limited < 0.1% 64,835 3.5M USD −75.1% reduced Q3 2020 8 quarters
HPE Hewlett Packard Enterprise < 0.1% 259,240 3.4M USD −71.6% reduced Q1 2022 2 quarters
Fluence Energy Inc < 0.1% 355,200 3.4M USD −55.4% reduced Q4 2021 3 quarters
Replimune Group Inc < 0.1% 187,800 3.3M USD −78.0% reduced Q4 2021 3 quarters
Proterra Inc < 0.1% 701,000 3.3M USD −24.4% reduced Q2 2021 5 quarters
2SEVENTY Bio Inc < 0.1% 238,300 3.1M USD −23.3% reduced Q4 2021 3 quarters
CRL Charles River Laboratories < 0.1% 14,513 3.1M USD −81.5% reduced Q3 2020 8 quarters
Tactile Sys Technology Inc < 0.1% 425,000 3.1M USD −46.0% reduced Q1 2022 2 quarters
Site Ctrs Corp < 0.1% 226,624 3.1M USD −8.4% reduced Q1 2022 2 quarters
Stag Indl Inc < 0.1% 97,332 3.0M USD −76.9% reduced Q4 2021 3 quarters
Impinj Inc < 0.1% 49,913 2.9M USD −39.3% reduced Q4 2021 3 quarters
NVO Novo Nordisk (ADR) < 0.1% 26,270 2.9M USD −95.5% reduced Q1 2022 2 quarters
Frontdoor Inc < 0.1% 115,000 2.8M USD −1.5% reduced Q1 2022 2 quarters
Prothena Corp PLC < 0.1% 99,900 2.7M USD −42.3% reduced Q2 2021 5 quarters
Gulfport Energy Corp < 0.1% 33,325 2.7M USD −49.5% reduced Q3 2021 4 quarters
Cameco Corp < 0.1% 125,000 2.6M USD −57.7% reduced Q1 2021 6 quarters
Figs Inc < 0.1% 279,700 2.5M USD −71.4% reduced Q1 2022 2 quarters
Ventyx Biosciences Inc < 0.1% 206,400 2.5M USD −8.8% reduced Q1 2022 2 quarters
Vertex Energy Inc < 0.1% 228,096 2.4M USD −32.9% reduced Q1 2022 2 quarters
Gh Research PLC < 0.1% 231,300 2.3M USD −15.1% reduced Q4 2021 3 quarters
Sunpower Corp < 0.1% 144,000 2.3M USD −47.0% reduced Q1 2022 2 quarters
FSLR First Solar < 0.1% 33,157 2.3M USD −91.3% reduced Q1 2022 2 quarters
EMR Emerson Electric < 0.1% 26,453 2.1M USD −88.9% reduced Q1 2022 2 quarters
AMP Ameriprise Financial < 0.1% 8,700 2.1M USD −45.3% reduced Q3 2021 4 quarters
Landec Corp < 0.1% 203,700 2.0M USD −22.1% reduced Q4 2021 3 quarters
Ishares TR < 0.1% 40,000 2.0M USD −46.7% reduced Q1 2020 10 quarters
Merrimack Pharmaceuticals In < 0.1% 335,108 2.0M USD −1.9% reduced Q2 2021 5 quarters
Lpl Finl HLDGS Inc < 0.1% 10,800 2.0M USD −83.9% reduced Q4 2020 7 quarters
Avid Bioservices Inc < 0.1% 128,600 2.0M USD −58.7% reduced Q1 2022 2 quarters
Nanostring Technologies Inc < 0.1% 149,989 1.9M USD −41.5% reduced Q3 2020 8 quarters
Amdocs Ltd < 0.1% 22,300 1.9M USD −89.9% reduced Q1 2022 2 quarters
Azure Pwr Global Ltd < 0.1% 161,500 1.8M USD −33.1% reduced Q3 2020 8 quarters
The Realreal Inc < 0.1% 734,600 1.8M USD −36.6% reduced Q1 2022 2 quarters
Adicet Bio Inc < 0.1% 124,900 1.8M USD −68.6% reduced Q1 2021 6 quarters
Childrens Pl Inc New < 0.1% 45,200 1.8M USD −61.1% reduced Q1 2019 14 quarters
NCLH Norwegian Cruise Line Holdings < 0.1% 152,908 1.7M USD −67.0% reduced Q3 2021 4 quarters
Harpoon Therapeutics Inc < 0.1% 870,700 1.7M USD −25.5% reduced Q4 2021 3 quarters
Sm Energy Co < 0.1% 46,900 1.6M USD −67.6% reduced Q3 2021 4 quarters
APO Apollo Global Management < 0.1% 32,800 1.6M USD −40.0% reduced Q1 2022 2 quarters
Renew Energy Global PLC < 0.1% 245,700 1.6M USD −34.4% reduced Q3 2021 4 quarters
Informatica Inc < 0.1% 75,300 1.6M USD −51.7% reduced Q4 2021 3 quarters
Builders Firstsource Inc < 0.1% 27,300 1.5M USD −88.9% reduced Q1 2021 6 quarters
Nextgen Healthcare Inc < 0.1% 83,600 1.5M USD −67.9% reduced Q4 2021 3 quarters
Lincoln Natl Corp Ind < 0.1% 29,100 1.4M USD −80.9% reduced Q3 2021 4 quarters
Mogo Inc < 0.1% 1,400,000 1.2M USD −30.3% reduced Q1 2021 6 quarters
PAYX Paychex < 0.1% 10,360 1.2M USD −78.9% reduced Q4 2021 3 quarters
ESS Essex Property Trust < 0.1% 4,200 1.1M USD −92.9% reduced Q4 2021 3 quarters
Eledon Pharmaceuticals Inc < 0.1% 428,360 1.0M USD −22.9% reduced Q1 2021 6 quarters
Convey Health Solutions Hldg < 0.1% 100,000 1.0M USD −65.2% reduced Q2 2021 5 quarters
Freyr Battery < 0.1% 151,104 1.0M USD −50.1% reduced Q3 2021 4 quarters
Atricure Inc < 0.1% 24,400 997.0K USD −84.7% reduced Q4 2021 3 quarters
Coherus Biosciences Inc < 0.1% 135,800 983.0K USD −80.8% reduced Q4 2021 3 quarters
Theravance Biopharma Inc < 0.1% 105,900 959.0K USD −83.9% reduced Q3 2021 4 quarters
Trinseo PLC < 0.1% 22,800 877.0K USD −0.4% reduced Q1 2022 2 quarters
Fusion Pharmaceuticals Inc < 0.1% 328,868 819.0K USD −6.0% reduced Q4 2020 7 quarters
Pardes Biosciences Inc < 0.1% 266,400 818.0K USD −38.4% reduced Q4 2021 3 quarters
Navitas Semiconductor Corp < 0.1% 207,600 801.0K USD −45.5% reduced Q4 2021 3 quarters
Cytokinetics Inc < 0.1% 19,633 771.0K USD −98.8% reduced Q2 2019 13 quarters
Neuropace Inc < 0.1% 149,199 739.0K USD −28.7% reduced Q4 2021 3 quarters
Ishares TR < 0.1% 10,000 736.0K USD −60.0% reduced Q4 2021 3 quarters
Community Health Sys Inc New < 0.1% 193,200 725.0K USD −93.0% reduced Q4 2021 3 quarters
Centessa Pharmaceuticals PLC < 0.1% 133,600 651.0K USD −85.3% reduced Q2 2021 5 quarters
F-Star Therapeutics Inc < 0.1% 91,761 574.0K USD −89.2% reduced Q1 2021 6 quarters
Revolution Medicines Inc < 0.1% 27,667 539.0K USD −92.9% reduced Q1 2022 2 quarters
Deutsche Bank A G < 0.1% 61,576 538.0K USD −88.4% reduced Q1 2022 2 quarters
RCL Royal Caribbean Group < 0.1% 14,200 496.0K USD −42.5% reduced Q1 2021 6 quarters
Conmed Corp < 0.1% 5,040 483.0K USD −94.5% reduced Q3 2021 4 quarters
Northwest Nat Hldg Co < 0.1% 8,500 451.0K USD −87.5% reduced Q1 2022 2 quarters
Surmodics Inc < 0.1% 11,500 428.0K USD −5.0% reduced Q4 2021 3 quarters
Sharecare Inc < 0.1% 265,000 419.0K USD −64.5% reduced Q3 2021 4 quarters
CIFR Cipher Mining < 0.1% 266,700 365.0K USD −43.3% reduced Q4 2021 3 quarters
Petmed Express Inc < 0.1% 16,900 336.0K USD −94.3% reduced Q3 2021 4 quarters
Lava Therapeutics NV < 0.1% 111,993 330.0K USD −4.3% reduced Q3 2021 4 quarters
Airsculpt Technologies Inc < 0.1% 49,200 292.0K USD −82.4% reduced Q4 2021 3 quarters
SNAP Snap < 0.1% 21,552 283.0K USD −94.1% reduced Q2 2021 5 quarters
Ligand Pharmaceuticals Inc < 0.1% 2,900 259.0K USD −96.6% reduced Q4 2021 3 quarters
PNC PNC Financial Services < 0.1% 1,644 259.0K USD −96.5% reduced Q1 2022 2 quarters
Praxis Precision Medicines I < 0.1% 100,000 245.0K USD −92.5% reduced Q4 2020 7 quarters
Aerie Pharmaceuticals Inc < 0.1% 31,900 239.0K USD −96.8% reduced Q1 2022 2 quarters
Ringcentral Inc < 0.1% 4,421 231.0K USD −98.1% reduced Q2 2020 9 quarters
Aptinyx Inc < 0.1% 410,416 229.0K USD −63.2% reduced Q4 2021 3 quarters
Liquidia Corporation < 0.1% 50,000 218.0K USD −82.3% reduced Q1 2022 2 quarters
Employers HLDGS Inc < 0.1% 4,200 176.0K USD −95.6% reduced Q3 2021 4 quarters
Athira Pharma Inc < 0.1% 55,000 168.0K USD −92.8% reduced Q4 2021 3 quarters
Gol Linhas Aereas Inteligent < 0.1% 40,900 139.0K USD −81.2% reduced Q3 2021 4 quarters
Cano Health Inc < 0.1% 22,500 99.0K USD −97.4% reduced Q1 2022 2 quarters
IREN IREN < 0.1% 16,500 55.0K USD −24.0% reduced Q4 2021 3 quarters
Electronic Arts Inc < 0.1% 394 48.0K USD −99.9% reduced Q2 2021 5 quarters
Aurora Innovation Inc < 0.1% 9,562 18.0K USD −96.8% reduced Q4 2021 3 quarters
Select Energy Svcs Inc < 0.1% 2,200 15.0K USD −63.9% reduced Q1 2022 2 quarters
James Riv Group Ltd < 0.1% 100 2.0K USD −91.7% reduced Q3 2021 4 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 358 option positions, value of the underlying shares as reported 2.4B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 643.9M USD
  • Invesco Db Multi-Sector Comm Call 96.1M USD
  • Select Sector SPDR TR Call 57.1M USD
  • Alibaba Group (ADR) Call 48.3M USD
  • Deere & Company Call 44.9M USD
  • Ishares TR Put 34.1M USD
  • American Airls Group Inc Put 30.2M USD
  • SPDR Ser TR Put 29.9M USD
  • Kohls Corp Call 28.6M USD
  • SPDR S&P 500 ETF TR Call 28.3M USD
Plus 38 positions in convertible bonds and bonds worth 350.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Novavax Inc principal 31.9M USD 32.0M USD
  • Dish Network Corporation principal 37.0M USD 26.2M USD
  • Spotify USA Inc principal 29.5M USD 23.5M USD
  • Sarepta Therapeutics Inc principal 17.0M USD 21.5M USD
  • Lumentum HLDGS Inc principal 20.0M USD 20.6M USD
  • Docusign Inc principal 17.5M USD 16.2M USD
  • Sunnova Energy Intl Inc. principal 18.3M USD 14.3M USD
  • Wayfair Inc principal 17.5M USD 14.0M USD
  • Wayfair Inc principal 20.5M USD 13.8M USD
  • Ford Mtr Co Del principal 15.0M USD 13.7M USD

Breakdown by sector

  • Technology 10.0%
  • Consumer Discretionary 7.5%
  • Health Care 7.2%
  • Financials 6.2%
  • Industrials 4.9%
  • Communication Services 4.0%
  • Consumer Staples 3.4%
  • Utilities 3.3%
  • Energy 2.6%
  • Materials 1.8%
  • Real Estate 1.4%
  • not in our coverage 47.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close